allotrap has been researched along with Chronic Illness in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Buelow, R; Coppola, D; Flanigan, A; Murthy, S | 1 |
Buelow, R; Fung, JJ; Iyer, S; Li, W; Lu, L; Qian, S; Rao, AS; Woo, J | 1 |
2 other study(ies) available for allotrap and Chronic Illness
Article | Year |
---|---|
RDP58, a locally active TNF inhibitor, is effective in the dextran sulphate mouse model of chronic colitis.
Topics: Animals; Biological Availability; Chronic Disease; Colitis, Ulcerative; Colon; Dextran Sulfate; Dogs; Feces; Female; Macaca mulatta; Mice; Occult Blood; Peptides; Tissue Distribution; Tumor Necrosis Factor-alpha | 2002 |
Attenuation of aortic graft arteriosclerosis by systemic administration of Allotrap peptide RDP58.
Topics: Animals; Aorta, Thoracic; Apoptosis; Arteriosclerosis; Autoantibodies; Cell Division; Cell Line; Chronic Disease; Complement System Proteins; Graft Rejection; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; Muscle, Smooth, Vascular; Peptides; Rats; Transplantation, Homologous; Tumor Necrosis Factor-alpha | 2003 |